Drilldown: Medicines
Appearance
Medicines > classes:
[[:Category:Statins|Statin]]
& onset
:
LDL lowering at 2 weeks, max by 4 weeks
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
& onset
:
LDL lowering at 2 weeks, max by 4 weeks
or
Postprandial glucose effect within days; HbA1c by 12 weeks 
Use the filters below to narrow your results.
~2 hours (parent and active β-hydroxy acid metabolite); pharmacodynamic effect lasts 24 hours via target turnover'"`UNIQ--ref-0000017A-QINU`"' (1) ·
~2-3 hours (parent); pharmacodynamic effect 24 hours via target turnover'"`UNIQ--ref-000003D5-QINU`"' (1) ·
~2-4 hours (parent and active β-hydroxy acid metabolite); pharmacodynamic effect 24 hours via target turnover'"`UNIQ--ref-00000807-QINU`"' (1)
<5% (extensive hepatic first-pass; food enhances absorption of IR, hence the evening-meal dosing)'"`UNIQ--ref-00000808-QINU`"' (1) ·
<5% (extensive hepatic first-pass; statin pharmacology is hepatocellular, not systemic)'"`UNIQ--ref-0000017B-QINU`"' (1) ·
~17% (oral; food slightly reduces absorption)'"`UNIQ--ref-000003D6-QINU`"' (1)
Showing below up to 3 results in range #1 to #3.

